XML 87 R73.htm IDEA: XBRL DOCUMENT v3.25.4
Shareholders’ Equity - Schedule of ATM Program Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Aug. 12, 2024
Oct. 25, 2023
Subsidiary, Sale of Stock [Line Items]          
Net proceeds $ 188,341,000 $ 135,475,000 $ 271,389,000    
Shares unsettled (in shares) 8,840,000        
Common stock          
Subsidiary, Sale of Stock [Line Items]          
Gross proceeds $ 52,446,000 98,731,000 131,911,000    
Net proceeds $ 51,562,000 $ 97,661,000 $ 130,274,000    
Number of shares sold (in shares) 3,185,262 5,983,711 7,662,341    
Weighted-average price (in dollars per share) $ 16.47 $ 16.50 $ 17.22    
Payment of deferred offering costs $ 884,000 $ 1,070,000 $ 1,638,000    
Common stock | 2023 ATM Program          
Subsidiary, Sale of Stock [Line Items]          
Gross proceeds 77,323,000        
Net proceeds 30,806,000        
Value of Gross Proceeds Available for Issuance $ 0        
Shares unsettled (in shares) 1,743,100        
Available net settlement price (in dollars per share) $ 17.25        
Weighted-average price (in dollars per share) $ 17.67        
Maximum Sales Authorization $ 300,000,000       $ 300,000,000.0
Common stock | 2024 ATM Program          
Subsidiary, Sale of Stock [Line Items]          
Gross proceeds 52,446,000        
Net proceeds 123,229,000        
Value of Gross Proceeds Available for Issuance $ 124,325,000        
Shares unsettled (in shares) 6,770,787 152,547      
Available net settlement price (in dollars per share) $ 17.94        
Weighted-average price (in dollars per share)   $ 17.13      
Maximum Sales Authorization $ 300,000,000     $ 300.0  
Common stock | Forward Sale Agreement          
Subsidiary, Sale of Stock [Line Items]          
Shares unsettled (in shares)   5,983,711 1,516,289    
Number of shares sold (in shares) 2,450,246        
Weighted-average price (in dollars per share) $ 16.47 $ 16.50 $ 16.49